Jiangsu Nhwa Pharmaceutical

Jiangsu Nhwa Pharmaceutical is one of the...

• CSI 500.

Jiangsu Nhwa Pharmaceutical is a company listed under the stock ticker 002262 (CN).

View the org chart displaying its 3 main executives

Most searched biographies at Jiangsu Nhwa Pharmaceutical

• Jiaquan Sun, Director and Chief Executive Officer
• Pengsheng Sun, Chairman of the Board
• Gangsheng Li, Chief Financial Officer

Create your alert
to follow the executive moves at Jiangsu Nhwa Pharmaceutical.

Jiangsu Nhwa Pharmaceutical has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Jiangsu Nhwa Pharmaceutical

Social media about Jiangsu Nhwa Pharmaceutical

• Jiangsu Nhwa Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Jiangsu Nhwa Pharmaceutical on LinkedIn, Twitter & YouTube

Call Jiangsu Nhwa Pharmaceutical at +86 516 ...

View the org chart

Register to receive your alert

Report an error